Skip to content

Industrial Pharmacist

  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy
  • ANDA
  • ADL
  • FRD
  • QbD
  • QA
  • QC
  • RA
  • FDA
  • VS
  • SCM
  • Q&A
  • Dissolution
  • Data Integrity
  • Validation
  • Manufacturing
  • Packaging
  • Microbiology
Industrial Pharmacist
  • Solubility and Stability in Preformulation Studies of Liquid Dosage Form
    Formulation Development

    Solubility and Stability in Preformulation Studies of Liquid Dosage Form

    Byipharmacist March 23, 2026March 23, 2026

    In liquid oral dosage form development, solubility is one of the most critical factors to assess during preformulation studies. The solubility of the active pharmaceutical ingredient (API) directly impacts its bioavailability — how effectively the body absorbs the drug. Without adequate solubility, the drug may not dissolve sufficiently to exert its therapeutic effect, leading to…

    Read More Solubility and Stability in Preformulation Studies of Liquid Dosage FormContinue

  • FDA Warning Letter on a Sterile Facility
    FDA Warning Letter

    FDA Warning Letter on a Sterile Facility

    Byipharmacist March 23, 2026March 23, 2026

    A recent FDA Warning Letter (10 March 2026) to Simtra BioPharma Solutions highlights a pattern the industry keeps seeing in sterile manufacturing. Not one failure but a chain of small ones. The result: FDA concluded the site could not reliably assure sterility. The lesson is simple. When these drift apart, regulators eventually connect the dots….

    Read More FDA Warning Letter on a Sterile FacilityContinue

  • Bioequivalence Studies: Key Concepts and Passing Limits
    Bioequivalence

    Bioequivalence Studies: Key Concepts and Passing Limits

    Byipharmacist March 23, 2026March 23, 2026

    Bioequivalence studies are fundamental in ensuring that generic drugs are as effective and safe as their brand-name counterparts. These studies compare the rate and extent of drug absorption in the body to demonstrate that a generic formulation behaves similarly to the reference product. But what defines a “passing” bioequivalence study? Let’s break it down: Bioequivalence…

    Read More Bioequivalence Studies: Key Concepts and Passing LimitsContinue

  • Quality by Design (QbD) Requirements in the EU and UK
    QbD

    Quality by Design (QbD) Requirements in the EU and UK

    Byipharmacist February 13, 2026February 13, 2026

    Quality by Design has become a central expectation in pharmaceutical development, even though it is not legally mandatory in either the EU or the UK. Both EMA and MHRA align fully with ICH Q8(R2), Q9(R1), Q10, Q11, and Q12, and expect a clear demonstration of product and process understanding for every new or complex formulation….

    Read More Quality by Design (QbD) Requirements in the EU and UKContinue

  • Common Technical Document (CTD) | The Global Language of Pharmaceutical Submissions
    eCTD

    Common Technical Document (CTD) | The Global Language of Pharmaceutical Submissions

    Byipharmacist February 7, 2026February 7, 2026

    The Common Technical Document (CTD) is one of the most significant harmonisation achievements in global regulatory science. Before CTD, every country required dossiers in different formats, leading to duplication, rework and delays in approvals. With the adoption of CTD, a single, harmonised structure now guides how quality, clinical and non-clinical data are organised for submission…

    Read More Common Technical Document (CTD) | The Global Language of Pharmaceutical SubmissionsContinue

  • A Simple Guide for Beginners in Pharmaceutical R&D
    Formulation Development

    A Simple Guide for Beginners in Pharmaceutical R&D

    Byipharmacist February 7, 2026February 7, 2026

    ONEFormulation development should always begin with understanding the drug substance. Before selecting any excipient, the scientist must know whether the API is soluble or insoluble, acidic or basic, hygroscopic or stable, and whether the dose is low or high. TWOThe reference product should be studied in detail. Its dosage form, strength, release behavior, labeling claims,…

    Read More A Simple Guide for Beginners in Pharmaceutical R&DContinue

  • Root Cause Mastery | From Correction to Prevention
    QA

    Root Cause Mastery | From Correction to Prevention

    Byipharmacist December 16, 2025December 16, 2025

    ROOT CAUSE ANALYSIS, WHERE QUALITY GROWS UP A strong Root Cause Analysis converts confusion into cause–and–effect clarity: 1) It separates symptoms from sources2) It turns firefighting into learning3) It transforms compliance into confidence HUMAN ERROR ≠ ROOT CAUSE Human actions are effects of system design & not the source of failure. Ask deeper questions:1) Was…

    Read More Root Cause Mastery | From Correction to PreventionContinue

  • Materials are Used in Pharmaceutical Blister Packs
    Packaging

    Materials are Used in Pharmaceutical Blister Packs

    Byipharmacist December 16, 2025December 16, 2025

    Aluminum Foil: Aluminum foil offers the highest barrier overall, against both moisture and oxygen, completely blocking light and gases. Aluminum foil used for highly sensitive drugs due to its exceptional impermeability. Ethylene Vinyl Alcohol (EVOH): oxygen barrier properties, particularly in dry conditions,but is moisture sensitive and often used in multilayer films with hydrophobic outer layers…

    Read More Materials are Used in Pharmaceutical Blister PacksContinue

Page navigation

1 2 3 … 45 Next PageNext

Popular Articles

  • How Expiry Dates Are Determined for Medicines?

    How Expiry Dates Are Determined for Medicines?

  • Difference Between HPLC and UHPLC

    Difference Between HPLC and UHPLC

  • Difference Between ISO Standards and EU GMP Annex 1

    Difference Between ISO Standards and EU GMP Annex 1

  • Titration in Pharmaceutical Industry

    Titration in Pharmaceutical Industry

  • Calculation of Peak Purity in HPLC

    Calculation of Peak Purity in HPLC

  • Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

    Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

  • Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

    Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

  • Audits in the Pharmaceutical Industry | Internal vs External

    Audits in the Pharmaceutical Industry | Internal vs External

  • USFDA Complaint Laboratory KPIs Measurements

    USFDA Complaint Laboratory KPIs Measurements

  • Difference Between Generic ANDA and 505(b)(2) Submissions

    Difference Between Generic ANDA and 505(b)(2) Submissions

  • Difference Between Disinfection and Sterilization

    Difference Between Disinfection and Sterilization

  • Key Elements of an Analytical Worksheet

    Key Elements of an Analytical Worksheet

  • Interview Questions and Answers on GMP

    Interview Questions and Answers on GMP

  • Quality by Design (QbD) and Design Space in Pharmaceutical Development

    Quality by Design (QbD) and Design Space in Pharmaceutical Development

  • CPP and CQA in Different Stages of Drug Product Manufacturing

    CPP and CQA in Different Stages of Drug Product Manufacturing

  • FDA Recall Classification System

    FDA Recall Classification System

  • Analytical Test Method Validation and Verification

    Analytical Test Method Validation and Verification

  • GLP vs GMP vs GCP | Similarities and Differences

    GLP vs GMP vs GCP | Similarities and Differences

  • Pharmaceutical Validation Interview Questions and Answers

    Pharmaceutical Validation Interview Questions and Answers

  • Difference Between Purity and Potency

    Difference Between Purity and Potency

© 2026 Industrial Pharmacist

  • Privacy Policy
  • DMCA
  • Contact Us
Industrial Pharmacist
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy